Chart of the Day: MRNA Bearish Trends Taking Control

Trial results from Moderna's (MRNA) melanoma drug sent shares of the healthcare giant soaring throughout the week, though Charles Schwab's Rachel Dashiell sees that strength subsiding for now. She points to bearish trends taking control of the stock and notes key levels to watch for a potential reversal.

Morning Movers

23 Jan 2026

SHARE

Schwab Network's Newsletters

Daily insights for every investor

ON AIR
4:00 pm
Fast Market
replay
12:00 am
Market Overtime
REPLAY
12:30 am
Market On Close
REPLAY
education
2:00 am
Schwab 2026 Outlook
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
5:00 am
Market Overtime
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Morning Movers
8:00 am
Opening Bell With Nicole Petallides
9:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
ON AIR
4:00 pm
Fast Market
REPLAY
5:00 pm
Next Gen Investing
REPLAY
6:00 pm
The Wrap
REPLAY
education
7:30 pm
Liz Ann Live
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market On Close
REPLAY
education
10:00 pm
Liz Ann Live
REPLAY
10:30 pm
The Wrap
REPLAY